Clinical Trials
1,105 trialsMulticenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Xiangya Hospital of Central South University
Evaluation and Treatment of Neurosurgical Disorders
National Institutes of Health Clinical Center (CC)
Natural History Study of Patients With Neurofibromatosis Type 2
National Institutes of Health Clinical Center (CC)
Natural History Study of Patients With Neurofibromatosis Type I
National Institutes of Health Clinical Center (CC)
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Tumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
Rare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
Cognitive Status After Removal of Skull Base Meningioma
Ohio State University
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
CSF-IMR
Medical University of Warsaw
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
M.D. Anderson Cancer Center
REVEAL
Ono Pharmaceutical Co., Ltd.
NEREUS
AstraZeneca
FET-BRAIN-DX
IRCCS San Raffaele
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
National Institutes of Health Clinical Center (CC)
LEARN
University of Sydney
MANGO
University of Sydney
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
University of California, San Francisco
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
SHINE-GLIO
University Hospital, Essen
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
VBS-CSI-PT-PED
Ruijin Hospital
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Massachusetts General Hospital
PEDIA
AstraZeneca
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
Washington University School of Medicine
DSOS
Duke University
Perioperative Evaluation of Cerebellar Tumors
Duke University
Gait in Young Children With NF1
NYU Langone Health
Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
Rigshospitalet, Denmark
SHAM INDYGO/DO
University Hospital, Lille
iCaRe2
University of Nebraska
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
BRAIN MATRIX
University of Birmingham
ResPGlioma
Universita degli Studi di Genova
CoDeB-Rad
University of Nottingham
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
National Institutes of Health Clinical Center (CC)
Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy
Washington University School of Medicine
Real-World Treatment Study of Koselugo (Selumetinib)
AstraZeneca
MR Elastography in Intracranial Lesions: Feasibility & Accuracy
Shengjing Hospital
MRinRT
Swansea Bay University Health Board
FCI-Glioblastoma Study
University of Aberdeen
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital
Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
National Institutes of Health Clinical Center (CC)
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Columbia University